Literature DB >> 10527036

Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects.

F Carmassi1, M Morale, L Ferrini, G Dell'Omo, M Ferdeghini, R Pedrinelli, F De Negri.   

Abstract

PURPOSE: Plasma levels of plasminogen activator inhibitor-1 are increased in obesity, hypertension, and diabetes. Their correlation with insulin levels supports the hypothesis that hypofibrinolysis may affect the development of atherosclerotic complications in patients with insulin resistance. To investigate the effect of insulin on fibrinolysis, we evaluated levels of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) antigens during insulin infusion in the forearm vascular beds of 8 healthy subjects.
MATERIALS AND METHODS: Insulin was infused in the brachial artery of each subject to raise local venous concentrations to approximately 100 microU/mL. Blood samples were obtained from the brachial artery and vein at baseline, after 30, 60, 90, and 120 minutes of infusion, and 30 minutes after the end of the infusion.
RESULTS: Following intra-arterial infusion of insulin, forearm blood flow (mean +/- SD) increased progressively from 2.7 +/- 0.6 to 4.0 +/- 0.6 mL/dL/min (P <0.01) and did not return to baseline after the end of the infusion. Plasminogen activator inhibitor-1 balance increased (345 +/- 160 versus 8 +/- 152 fmol/dL/min, P <0.02) at 60 minutes, reaching baseline levels after the end of the infusion. After 90 minutes, tPA balance increased (40 +/- 26 versus 7 +/- 29 fmol/dL/min, P <0.01) with a profile similar to forearm blood flow.
CONCLUSIONS: Local hyperinsulinemia induces regional vasodilation and expression of PAI-1 and tPA antigens. An alteration of this physiological process could be involved in the development of hypofibrinolysis and atherosclerosis in states of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527036     DOI: 10.1016/s0002-9343(99)00240-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.

Authors:  Franca Fruzzetti; Lorenzo Ghiadoni; Agostino Virdis; Ferdinando De Negri; Daria Perini; Fiorella Bucci; Chiara Giannarelli; Angiolo Gadducci; Stefano Taddei
Journal:  J Pediatr Adolesc Gynecol       Date:  2016-03-24       Impact factor: 1.814

2.  Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.

Authors:  Veeral Ajmera; Emily R Perito; Nathan M Bass; Norah A Terrault; Katherine P Yates; Ryan Gill; Rohit Loomba; Anna Mae Diehl; Bradley E Aouizerat
Journal:  Hepatology       Date:  2016-10-12       Impact factor: 17.425

3.  Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1.

Authors:  Ushma R Jag; Jiri Zavadil; Frederick M Stanley
Journal:  Mol Endocrinol       Date:  2009-07-16

4.  PAI-1 and diabetes: a journey from the bench to the bedside.

Authors:  David J Schneider; Burton E Sobel
Journal:  Diabetes Care       Date:  2012-10       Impact factor: 19.112

5.  Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity.

Authors:  Katarina Lalić; Aleksandra Jotić; Nataša Rajković; Sandra Singh; Ljubica Stošić; Ljiljana Popović; Ljiljana Lukić; Tanja Miličić; Jelena P Seferović; Marija Maćešić; Jelena Stanarčić; Milorad Čivčić; Iva Kadić; Nebojša M Lalić
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

6.  Platelet counts are associated with arterial stiffness in Chinese Han population: a longitudinal study.

Authors:  Kuo Liu; Junfeng Xu; Lixin Tao; Kun Yang; Yang Sun; Xiuhua Guo
Journal:  BMC Cardiovasc Disord       Date:  2020-07-30       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.